Study Group: Illumina's SNP Chip Users (US)
Council Members in this Study Group: 45
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
Ken PowellPresident
Genesis Business Development, LLC
Ken Powell is the President of Genesis Business Development, a healthcare consultancy. Mr. Powell has experience in the identification, acquisition, and commercialization of intellectual property, new businesses, and products in the clinical diagnostics...
Gregory KhitrovDirector of Personalized Medicine Program
MOUNT SINAI SCHOOL OF MEDICINE OFGreg Khitrov, PhD, is the Director of Institutes for Personalized Medicine Core Laboratory, Director of Biobank and an Assistant Professor of Medicine at the Mount Sinai School of Medicine in New York. He has expertise in molecular biology; proteomics;...
GLG NewsSM Analyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
Will Quest Acquire Vermillion?
November 20, 2009
Analysis by: Ken Powell, President,Why Quest Will Acquire Vermillion | www.genomeweb.com
Quest Diagnostics has had a known relationship with Vermillion. Now that Vermillion has received FDA approval for its OVA1 in vitro diagnostic multi-variant index assay (IVDMIA) and Quest has an exclusive three year marketing license and a 17% investment in the company plus additional loans, acquisition of Vermillion could make sense for both companies.
-
Roche Receives H1N1 FDA Emergency Use Authorization
November 16, 2009
Analysis by: Ken Powell, President,Roche Gets FDA EUA for H1N1 Test Kit | www.genomeweb.com
Roche has received an Emergency Use Authorization from the FDA for its RealTime ready Influenza A/H1N1 Detection Set. The new H1N1 assay is run on its MagNA Pure LC platform for nucleic acid isolation and its LightCycler 2.0 system for real-time PCR applications. Roche, the worldwide clinical diagnostics leader should have an advantage in the H1N1 market segment.
-
November 14, 2009
Analysis by: Ken Powell, President,Sequenom Shareholders Sue Company, Officials over SEQureDx Data Mishandling | www.genomeweb.com
The Sequenom sage appears endless. Following the "mishandling of data" involving the company's Down's syndrome test, termination of company executives, investigation by the NASDAQ , the SEC and the US Attorney for the Southern District of California, Xenomics lawsuit against Sequenom seeking up to $300 million in damages, Sequenom shareholders have filed a suit against the company and several individual current and former executives . The news continues to mount and none of it is good.
-
Epigenomics Reports Excellent 3Q Returns
November 12, 2009
Analysis by: Ken Powell, President,Epigenomics Nearly Quadruples Sales in Q3 | www.genomeweb.com
Germany based Epigenomics posted stellar Q3 financial results and reduced net loss by 8%. According to the company, the increase comes from existing collaborations, new partnerships, and license agreements
-
November 12, 2009
Analysis by: Ken Powell, President,Life Technologies to Buy Biotrove, Which Will Form Mass Spec Sample Prep Company | www.biotrove.com
Following on Life Technologies' (NASDAQ: LIFE) acquisition of Biotrove, Biotrove announced in a separate release that it will form a subsidiary for a sample handing company for mass spectroscopy systems. This could be the real opportunity for future growth.
Members in this Study Group include these company types:
- Academic Medical Center/Hospital or Clinic
- Academic Institution*
- Research Foundation
- Pharmaceuticals Manufacturer
- Office Based Private Practice or Clinic
Members in this Study Group often have these job titles:
- Physician - Attending Physician
- Research Scientist
- Director
- Professor
- Physician - Director
- Physician - Department Chair
- Assistant Professor
- Researcher
Related Study Groups
GLG Live Meetings with this Study Group's Leading Experts (?)
April 26, 2007 | New York
GLGi: Genotyping TechnologiesGLG Webcasts & Teleconferences
Leading Experts in Illumina's SNP Chip Users (US) have not participated in any GLG webcasts.